{
    "clinical_study": {
        "@rank": "14828", 
        "arm_group": [
            {
                "arm_group_label": "Dual Focus Soft Contact Lens", 
                "arm_group_type": "Experimental", 
                "description": "Dual Focus Soft Contact Lens"
            }, 
            {
                "arm_group_label": "Single Vision Soft Contact Lens", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Single Vision Soft Contact Lens"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether a new type of soft contact lens with a\n      unique optical design (dual focus) is effective at slowing the progression of myopia\n      (near-sightedness) in children."
        }, 
        "brief_title": "An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Myopia", 
        "condition_browse": {
            "mesh_term": "Myopia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be between 8 and 12 years of age inclusive.\n\n          -  Best-corrected visual acuity by manifest refraction of +0.10 logMAR.\n\n          -  Spherical Equivalent Refractive Error between -0.75 and -4.00 D inclusive\n             astigmatism: < -0.75 D anisometropia: < 1.00 D\n\n          -  Possess wearable and visually functional eyeglasses.\n\n          -  Agree to wear the assigned contact lenses for a minimum of 10 hours per day, - at\n             least 6 days per week, for the duration of the 3 year study.\n\n        Exclusion Criteria:\n\n          -  Subject has previously or currently wears contact lenses or rigid gas permeable\n             contact lenses, including orthokeratology lenses.\n\n          -  Subject is currently or within 30 days prior to this study has been an active\n             participant in another clinical study.\n\n          -  Current or prior use of bifocals, progressive addition lenses, atropine, pirenzepine\n             or ANY other myopia control treatment.\n\n          -  Regular use of ocular medications (prescription or over-the-counter), artificial\n             tears, or wetting agents.\n\n          -  Current use of systemic medications which may significantly affect contact lens wear,\n             tear film production, pupil size, accommodation or refractive state.\n\n          -  A known allergy to fluorescein, benoxinate, proparacaine or tropicamide.\n\n          -  Strabismus by cover test at far (4 m) or near (40 cm) wearing distance correction.\n\n          -  Any ocular, systemic or neuro-developmental conditions that could influence\n             refractive development."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01729208", 
            "org_study_id": "CVI08008"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dual Focus Soft Contact Lens", 
                "intervention_name": "Dual Focus Soft Contact Lens", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Single Vision Soft Contact Lens", 
                "intervention_name": "Single Vision Soft Contact Lens", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "myopia progression", 
            "myopia control"
        ], 
        "lastchanged_date": "February 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Waterloo", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N2L 3G1"
                    }, 
                    "name": "University of Waterloo School of Optometry"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Braga", 
                        "country": "Portugal", 
                        "zip": "4710-057"
                    }, 
                    "name": "University of Minho Clinical & Experiment Optometry Research Lab"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore", 
                        "zip": "117597"
                    }, 
                    "name": "National University of Singapore Faculty of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom", 
                        "zip": "B4 7ET"
                    }, 
                    "name": "Aston University Ophthalmic Research Group"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Canada", 
                "Portugal", 
                "Singapore", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicentre Dispensing Clinical Evaluation of MiSight\u00ae Lenses", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in refractive error relative to baseline", 
                "safety_issue": "No", 
                "time_frame": "yearly for 3 years"
            }, 
            {
                "measure": "Change in axial length relative to baseline", 
                "safety_issue": "No", 
                "time_frame": "yearly for 3 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01729208"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Incidence of adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "3 years"
        }, 
        "source": "Coopervision, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Visioncare Research Ltd.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Coopervision, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}